Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Ion Beam Applications SA (IBAB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011164
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solutions, radiopharmacy solutions and particle accelerators. IBA’s products and services find application in the treatment of cancer and neurologic and cardiac disorders. It also provides sterilization and ionization solutions for industrial uses. The company has operational presence in North America, South America, Europe and Asia. IBA is headquartered in Louvain la Neuve, Walloon Brabant, Belgium.

Ion Beam Applications SA (IBAB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ion Beam Applications SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ion Beam Applications SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ion Beam Applications SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ion Beam Applications SA, Medical Equipment, Deal Details 12
Venture Financing 12
HIL Applied Medical Raises Funds in Series C Financing 12
Private Equity 13
CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 13
Argos Soditic Completes Management Buyout Of Cisbio Bioassays For US$32.4 Million 14
SK Capital Partners Acquires 60% Stake In IBA Molecular Imaging From Ion Beam Applications For US$234 Million 16
Partnerships 18
Elekta to Enter into Agreement with IBA 18
Royal Philips, Singapore Institute of Advanced Medicine Forms Joint Venture with Varian Medical Systems and Ion Beam Applications 19
Ion Beam Applications Enters into Agreement with Koninklijke Philips 21
IBA Partners with Philips India 22
Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 23
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 24
Ion Beam Applications Enters into Co-Development Agreement with Mobius Medical Systems 25
RaySearch And Ion Beam Applications Enter Into Agreement To Develop Proton Treatment Planning System 26
IBA Group Enters Into An Agreement With Royal Philips Electronics 27
IBA Dosimetry Enters Into Distribution Agreement With Axios Oncology 28
Acquisition 29
Ion Beam Applications Acquires 25% Stake In PET Net 29
Ion Beam Applications SA – Key Competitors 30
Ion Beam Applications SA – Key Employees 31
Ion Beam Applications SA – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Strategy And Business Planning 34
Sep 25, 2016: IBA and Philips step up collaboration in adaptive proton therapy planning to advance personalized cancer care 34
Financial Announcements 35
Nov 16, 2017: IBA Trading Update – Third Quarter 2017 35
Aug 24, 2017: IBA Reports Half Year Results for 2017 37
May 10, 2017: IBA trading update – first quarter 2017 38
Nov 16, 2016: IBA Trading Update – Third Quarter 2016 39
Aug 25, 2016: IBA Reports Half Year 2016 Results 41
May 11, 2016: IBA Trading Update – First Quarter 2016 42
Feb 17, 2016: IBA announces 2016 guidance and upgrades 2015 expectations 44
Corporate Communications 45
Jun 02, 2016: IBA Strengthens Management Team For Future Growth 45
Government and Public Interest 46
Jun 14, 2016: Proton Therapy Arrives at Miami Cancer Institute 46
Product News 47
02/02/2016: HUPTI Advances Cancer Treatment to Another Level for Cancer Patients With the Addition of Pencil Beam Scanning 47
Other Significant Developments 48
Sep 27, 2016: IBA’s Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated 48
Sep 23, 2016: IBA to open the path towards adaptive proton therapy 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Ion Beam Applications SA, Medical Equipment, Key Facts, 2016 2
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ion Beam Applications SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ion Beam Applications SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ion Beam Applications SA, Deals By Market, 2011 to YTD 2017 9
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
HIL Applied Medical Raises Funds in Series C Financing 12
CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 13
Argos Soditic Completes Management Buyout Of Cisbio Bioassays For US$32.4 Million 14
SK Capital Partners Acquires 60% Stake In IBA Molecular Imaging From Ion Beam Applications For US$234 Million 16
Elekta to Enter into Agreement with IBA 18
Royal Philips, Singapore Institute of Advanced Medicine Forms Joint Venture with Varian Medical Systems and Ion Beam Applications 19
Ion Beam Applications Enters into Agreement with Koninklijke Philips 21
IBA Partners with Philips India 22
Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 23
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 24
Ion Beam Applications Enters into Co-Development Agreement with Mobius Medical Systems 25
RaySearch And Ion Beam Applications Enter Into Agreement To Develop Proton Treatment Planning System 26
IBA Group Enters Into An Agreement With Royal Philips Electronics 27
IBA Dosimetry Enters Into Distribution Agreement With Axios Oncology 28
Ion Beam Applications Acquires 25% Stake In PET Net 29
Ion Beam Applications SA, Key Competitors 30
Ion Beam Applications SA, Key Employees 31
Ion Beam Applications SA, Subsidiaries 32

★海外企業調査レポート[Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ameresco Inc (AMRC)-エネルギー分野:企業M&A・提携分析
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …
  • InflaRx NV (IFRX):製薬・医療:M&Aディール及び事業提携情報
    Summary InflaRx NV (InflaRx) is a clinical-stage biopharmaceutical company that develops therapies in the field of acute and chronic inflammation. The company offers development of monoclonal antibodies targeting activation products of the complement system for application in threatening inflammator …
  • Target Corp:企業の戦略・SWOT・財務情報
    Target Corp - Strategy, SWOT and Corporate Finance Report Summary Target Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Integrated Silicon Solution, Inc.:企業の戦略的SWOT分析
    Integrated Silicon Solution, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • OraSure Technologies Inc (OSUR)-製薬・医療分野:企業M&A・提携分析
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and ant …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • ARM Holdings plc:企業のM&A・事業提携・投資動向
    ARM Holdings plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ARM Holdings plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Marico Limited (MARICO):企業の財務・戦略的SWOT分析
    Marico Limited (MARICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Herantis Pharma Plc (HRTIS):医療機器:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • China General Nuclear Power Corp (1816):企業の財務・戦略的SWOT分析
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …
  • Gritstone Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gritstone Oncology Inc (Gritstone) is a cancer immunotherapy company which focuses on the development of personalized cancer therapeutics. The company primarily concentrates on identifying and deploying the therapeutic neo-antigens from individual patients’ tumors for the development of nove …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Playtech PLC:企業のM&A・事業提携・投資動向
    Playtech PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Playtech PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Lincoln Educational Services Corp (LINC):企業の財務・戦略的SWOT分析
    Summary Lincoln Educational Services Corp (Lincoln) is an educational service provider that operates schools, colleges and technical institutes. The organization offers student services including admissions, financial aid, academics, and career services. It provides educational programs in the areas …
  • DxTerity Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population scale genomic studies. …
  • Aramark (ARMK):企業の財務・戦略的SWOT分析
    Aramark (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Georox Resources Inc (GXR):石油・ガス:M&Aディール及び事業提携情報
    Summary Georox Resources Inc (Georox Resources), formerly Oromonte Resources Inc is an oil and gas company that acquires, develops and explores petroleum and natural gas properties in Western Canada. The company's projects include Silverdale property, GP Channel project, Sparky Non Channel project, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆